Estrella Immunopharma Announces Closing of $8.0 Million Registered Direct Offering and Concurrent Private Placement

Core Viewpoint - Estrella Immunopharma, Inc. has successfully closed a registered direct offering with a healthcare-focused institutional investor, raising capital through the issuance of common stock and pre-funded warrants [1] Group 1: Offering Details - The company issued and sold a total of 4,063,290 shares of its common stock [1] - Additionally, the offering included 1,000,000 pre-funded warrants [1]